Intrinsic value of AMN Healthcare Services - AMN

Previous Close

$52.20

  Intrinsic Value

$135.56

stock screener

  Rating & Target

str. buy

+160%

Previous close

$52.20

 
Intrinsic value

$135.56

 
Up/down potential

+160%

 
Rating

str. buy

We calculate the intrinsic value of AMN stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 2.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  13.90
  13.01
  12.21
  11.49
  10.84
  10.26
  9.73
  9.26
  8.83
  8.45
  8.10
  7.79
  7.51
  7.26
  7.04
  6.83
  6.65
  6.48
  6.34
  6.20
  6.08
  5.97
  5.88
  5.79
  5.71
  5.64
  5.58
  5.52
  5.47
  5.42
Revenue, $m
  2,265
  2,560
  2,872
  3,202
  3,549
  3,913
  4,294
  4,691
  5,105
  5,537
  5,985
  6,452
  6,937
  7,440
  7,964
  8,508
  9,074
  9,662
  10,274
  10,911
  11,575
  12,267
  12,987
  13,739
  14,524
  15,343
  16,198
  17,092
  18,026
  19,003
Variable operating expenses, $m
  1,720
  1,937
  2,166
  2,408
  2,663
  2,931
  3,210
  3,502
  3,806
  4,123
  4,396
  4,739
  5,095
  5,465
  5,849
  6,249
  6,664
  7,096
  7,546
  8,014
  8,501
  9,009
  9,539
  10,091
  10,667
  11,268
  11,897
  12,553
  13,239
  13,957
Fixed operating expenses, $m
  272
  278
  284
  290
  297
  303
  310
  317
  324
  331
  338
  345
  353
  361
  369
  377
  385
  394
  402
  411
  420
  429
  439
  448
  458
  468
  479
  489
  500
  511
Total operating expenses, $m
  1,992
  2,215
  2,450
  2,698
  2,960
  3,234
  3,520
  3,819
  4,130
  4,454
  4,734
  5,084
  5,448
  5,826
  6,218
  6,626
  7,049
  7,490
  7,948
  8,425
  8,921
  9,438
  9,978
  10,539
  11,125
  11,736
  12,376
  13,042
  13,739
  14,468
Operating income, $m
  273
  345
  422
  503
  589
  679
  774
  872
  975
  1,083
  1,251
  1,368
  1,489
  1,615
  1,746
  1,883
  2,024
  2,172
  2,326
  2,486
  2,654
  2,828
  3,010
  3,200
  3,398
  3,606
  3,823
  4,049
  4,287
  4,535
EBITDA, $m
  350
  425
  504
  589
  678
  771
  869
  971
  1,078
  1,189
  1,305
  1,426
  1,551
  1,682
  1,817
  1,959
  2,106
  2,259
  2,418
  2,584
  2,757
  2,938
  3,126
  3,323
  3,528
  3,743
  3,968
  4,202
  4,448
  4,705
Interest expense (income), $m
  8
  19
  24
  30
  36
  43
  50
  57
  65
  73
  81
  90
  99
  109
  118
  128
  139
  150
  161
  173
  186
  198
  212
  226
  240
  255
  271
  288
  305
  323
  342
Earnings before tax, $m
  254
  321
  392
  467
  546
  629
  716
  807
  902
  1,001
  1,161
  1,269
  1,381
  1,497
  1,618
  1,743
  1,874
  2,011
  2,153
  2,301
  2,455
  2,616
  2,784
  2,960
  3,143
  3,335
  3,535
  3,744
  3,964
  4,193
Tax expense, $m
  69
  87
  106
  126
  147
  170
  193
  218
  244
  270
  314
  343
  373
  404
  437
  471
  506
  543
  581
  621
  663
  706
  752
  799
  849
  900
  954
  1,011
  1,070
  1,132
Net income, $m
  186
  234
  286
  341
  399
  459
  523
  589
  659
  731
  848
  926
  1,008
  1,093
  1,181
  1,273
  1,368
  1,468
  1,572
  1,680
  1,792
  1,910
  2,032
  2,161
  2,294
  2,434
  2,580
  2,733
  2,894
  3,061

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  1,429
  1,615
  1,812
  2,020
  2,239
  2,469
  2,709
  2,960
  3,221
  3,493
  3,776
  4,071
  4,376
  4,694
  5,025
  5,368
  5,725
  6,096
  6,482
  6,884
  7,303
  7,739
  8,194
  8,668
  9,163
  9,680
  10,220
  10,783
  11,373
  11,989
Adjusted assets (=assets-cash), $m
  1,429
  1,615
  1,812
  2,020
  2,239
  2,469
  2,709
  2,960
  3,221
  3,493
  3,776
  4,071
  4,376
  4,694
  5,025
  5,368
  5,725
  6,096
  6,482
  6,884
  7,303
  7,739
  8,194
  8,668
  9,163
  9,680
  10,220
  10,783
  11,373
  11,989
Revenue / Adjusted assets
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
  1.585
Average production assets, $m
  405
  458
  514
  573
  635
  700
  769
  840
  914
  991
  1,071
  1,155
  1,242
  1,332
  1,426
  1,523
  1,624
  1,730
  1,839
  1,953
  2,072
  2,196
  2,325
  2,459
  2,600
  2,746
  2,899
  3,059
  3,227
  3,402
Working capital, $m
  147
  166
  187
  208
  231
  254
  279
  305
  332
  360
  389
  419
  451
  484
  518
  553
  590
  628
  668
  709
  752
  797
  844
  893
  944
  997
  1,053
  1,111
  1,172
  1,235
Total debt, $m
  416
  518
  627
  742
  862
  989
  1,121
  1,259
  1,403
  1,553
  1,709
  1,871
  2,040
  2,215
  2,397
  2,586
  2,783
  2,987
  3,200
  3,422
  3,652
  3,893
  4,143
  4,405
  4,677
  4,962
  5,259
  5,570
  5,895
  6,234
Total liabilities, $m
  787
  890
  998
  1,113
  1,234
  1,360
  1,493
  1,631
  1,775
  1,925
  2,081
  2,243
  2,411
  2,587
  2,769
  2,958
  3,154
  3,359
  3,572
  3,793
  4,024
  4,264
  4,515
  4,776
  5,049
  5,334
  5,631
  5,942
  6,266
  6,606
Total equity, $m
  642
  725
  814
  907
  1,005
  1,108
  1,216
  1,329
  1,446
  1,568
  1,696
  1,828
  1,965
  2,108
  2,256
  2,410
  2,570
  2,737
  2,910
  3,091
  3,279
  3,475
  3,679
  3,892
  4,114
  4,346
  4,589
  4,842
  5,106
  5,383
Total liabilities and equity, $m
  1,429
  1,615
  1,812
  2,020
  2,239
  2,468
  2,709
  2,960
  3,221
  3,493
  3,777
  4,071
  4,376
  4,695
  5,025
  5,368
  5,724
  6,096
  6,482
  6,884
  7,303
  7,739
  8,194
  8,668
  9,163
  9,680
  10,220
  10,784
  11,372
  11,989
Debt-to-equity ratio
  0.650
  0.710
  0.770
  0.820
  0.860
  0.890
  0.920
  0.950
  0.970
  0.990
  1.010
  1.020
  1.040
  1.050
  1.060
  1.070
  1.080
  1.090
  1.100
  1.110
  1.110
  1.120
  1.130
  1.130
  1.140
  1.140
  1.150
  1.150
  1.150
  1.160
Adjusted equity ratio
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449
  0.449

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  186
  234
  286
  341
  399
  459
  523
  589
  659
  731
  848
  926
  1,008
  1,093
  1,181
  1,273
  1,368
  1,468
  1,572
  1,680
  1,792
  1,910
  2,032
  2,161
  2,294
  2,434
  2,580
  2,733
  2,894
  3,061
Depreciation, amort., depletion, $m
  77
  80
  82
  85
  89
  92
  95
  99
  102
  106
  54
  58
  62
  67
  71
  76
  81
  86
  92
  98
  104
  110
  116
  123
  130
  137
  145
  153
  161
  170
Funds from operations, $m
  263
  314
  369
  426
  487
  551
  618
  688
  761
  837
  901
  984
  1,070
  1,159
  1,252
  1,349
  1,450
  1,554
  1,664
  1,777
  1,896
  2,020
  2,149
  2,284
  2,424
  2,572
  2,725
  2,886
  3,055
  3,231
Change in working capital, $m
  18
  19
  20
  21
  23
  24
  25
  26
  27
  28
  29
  30
  32
  33
  34
  35
  37
  38
  40
  41
  43
  45
  47
  49
  51
  53
  56
  58
  61
  63
Cash from operations, $m
  245
  295
  348
  405
  465
  527
  593
  662
  734
  809
  872
  954
  1,038
  1,126
  1,218
  1,314
  1,413
  1,516
  1,624
  1,736
  1,853
  1,975
  2,102
  2,235
  2,373
  2,518
  2,670
  2,828
  2,994
  3,168
Maintenance CAPEX, $m
  -18
  -20
  -23
  -26
  -29
  -32
  -35
  -38
  -42
  -46
  -50
  -54
  -58
  -62
  -67
  -71
  -76
  -81
  -86
  -92
  -98
  -104
  -110
  -116
  -123
  -130
  -137
  -145
  -153
  -161
New CAPEX, $m
  -50
  -53
  -56
  -59
  -62
  -65
  -68
  -71
  -74
  -77
  -80
  -83
  -87
  -90
  -94
  -97
  -101
  -105
  -110
  -114
  -119
  -124
  -129
  -135
  -140
  -147
  -153
  -160
  -167
  -175
Cash from investing activities, $m
  -68
  -73
  -79
  -85
  -91
  -97
  -103
  -109
  -116
  -123
  -130
  -137
  -145
  -152
  -161
  -168
  -177
  -186
  -196
  -206
  -217
  -228
  -239
  -251
  -263
  -277
  -290
  -305
  -320
  -336
Free cash flow, $m
  177
  222
  269
  320
  374
  431
  490
  553
  618
  686
  742
  817
  894
  974
  1,058
  1,145
  1,235
  1,330
  1,428
  1,530
  1,636
  1,747
  1,863
  1,984
  2,110
  2,242
  2,379
  2,523
  2,674
  2,832
Issuance/(repayment) of debt, $m
  96
  102
  109
  115
  121
  127
  132
  138
  144
  150
  156
  162
  169
  175
  182
  189
  197
  205
  213
  222
  231
  240
  251
  261
  273
  285
  297
  311
  325
  340
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  96
  102
  109
  115
  121
  127
  132
  138
  144
  150
  156
  162
  169
  175
  182
  189
  197
  205
  213
  222
  231
  240
  251
  261
  273
  285
  297
  311
  325
  340
Total cash flow (excl. dividends), $m
  273
  324
  378
  435
  494
  557
  623
  691
  762
  836
  898
  979
  1,062
  1,149
  1,240
  1,334
  1,432
  1,534
  1,640
  1,751
  1,867
  1,988
  2,114
  2,245
  2,383
  2,526
  2,677
  2,834
  2,999
  3,171
Retained Cash Flow (-), $m
  -79
  -83
  -89
  -93
  -98
  -103
  -108
  -113
  -117
  -122
  -127
  -132
  -137
  -143
  -148
  -154
  -160
  -167
  -173
  -181
  -188
  -196
  -204
  -213
  -222
  -232
  -242
  -253
  -265
  -277
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  194
  241
  290
  341
  396
  454
  515
  578
  645
  714
  771
  847
  925
  1,007
  1,092
  1,180
  1,272
  1,367
  1,467
  1,571
  1,679
  1,792
  1,909
  2,032
  2,160
  2,294
  2,434
  2,581
  2,734
  2,894
Discount rate, %
  4.60
  4.83
  5.07
  5.33
  5.59
  5.87
  6.16
  6.47
  6.80
  7.14
  7.49
  7.87
  8.26
  8.67
  9.11
  9.56
  10.04
  10.54
  11.07
  11.62
  12.21
  12.82
  13.46
  14.13
  14.84
  15.58
  16.36
  17.17
  18.03
  18.93
PV of cash for distribution, $m
  185
  219
  250
  277
  302
  322
  339
  350
  357
  358
  348
  341
  330
  314
  295
  274
  250
  225
  200
  174
  150
  126
  105
  85
  68
  53
  41
  31
  22
  16
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services at acute and sub-acute care hospitals and other healthcare facilities throughout the United States. The Company's segments include nurse and allied solutions, locum tenens solutions and other workforce solutions. Through its suite of solutions, the Company provides technology, analytics and services to build and manage all or a portion of its clients' healthcare workforce needs, from nurses, doctors and allied health professionals to healthcare leaders and executives. It offers managed services programs, vendor management systems, predictive analytics, workforce optimization consulting, recruitment process outsourcing, interim and executive leadership, and remote medical coding. It offers various services, including travel nurse staffing; local, or per diem, staffing; locum tenens staffing; allied staffing; physician permanent placement services, and health information management.

FINANCIAL RATIOS  of  AMN Healthcare Services (AMN)

Valuation Ratios
P/E Ratio 23.4
Price to Sales 1.3
Price to Book 5.5
Price to Tangible Book
Price to Cash Flow 18.8
Price to Free Cash Flow 22.6
Growth Rates
Sales Growth Rate 30%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -18.5%
Cap. Spend. - 3 Yr. Gr. Rate 19.6%
Financial Strength
Quick Ratio 3
Current Ratio 0.1
LT Debt to Equity 80%
Total Debt to Equity 80.8%
Interest Coverage 23
Management Effectiveness
Return On Assets 10.7%
Ret/ On Assets - 3 Yr. Avg. 9.1%
Return On Total Capital 16.4%
Ret/ On T. Cap. - 3 Yr. Avg. 14.5%
Return On Equity 26.6%
Return On Equity - 3 Yr. Avg. 22.5%
Asset Turnover 1.8
Profitability Ratios
Gross Margin 32.6%
Gross Margin - 3 Yr. Avg. 31.7%
EBITDA Margin 11.3%
EBITDA Margin - 3 Yr. Avg. 9.7%
Operating Margin 10%
Oper. Margin - 3 Yr. Avg. 8.4%
Pre-Tax Margin 9.3%
Pre-Tax Margin - 3 Yr. Avg. 7.7%
Net Profit Margin 5.6%
Net Profit Margin - 3 Yr. Avg. 4.8%
Effective Tax Rate 39.8%
Eff/ Tax Rate - 3 Yr. Avg. 38.7%
Payout Ratio 0%

AMN stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the AMN stock intrinsic value calculation we used $1988.454 million for the last fiscal year's total revenue generated by AMN Healthcare Services. The default revenue input number comes from 0001 income statement of AMN Healthcare Services. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our AMN stock valuation model: a) initial revenue growth rate of 13.9% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.6%, whose default value for AMN is calculated based on our internal credit rating of AMN Healthcare Services, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of AMN Healthcare Services.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of AMN stock the variable cost ratio is equal to 76.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $266 million in the base year in the intrinsic value calculation for AMN stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.8% for AMN Healthcare Services.

Corporate tax rate of 27% is the nominal tax rate for AMN Healthcare Services. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the AMN stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for AMN are equal to 17.9%.

Life of production assets of 20 years is the average useful life of capital assets used in AMN Healthcare Services operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for AMN is equal to 6.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $562.527 million for AMN Healthcare Services - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 47.493 million for AMN Healthcare Services is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of AMN Healthcare Services at the current share price and the inputted number of shares is $2.5 billion.

RELATED COMPANIES Price Int.Val. Rating
AMN AMN Healthcare 52.20 138.51  str.buy
CCRN Cross Country 8.31 9.97  hold
PINC Premier 44.80 84.69  str.buy
HCA HCA Healthcare 133.71 41.29  str.sell
KELYA Kelly Services 22.70 71.54  str.buy
ASGN ASGN 62.90 82.39  hold

COMPANY NEWS

▶ AMN Healthcare: 2Q Earnings Snapshot   [05:03AM  Associated Press]
▶ AMN Healthcare Announces Second Quarter 2018 Results   [Aug-02-18 04:15PM  PR Newswire]
▶ Nation's largest health care staffing firm planning major DFW expansion   [Jun-19-18 03:45PM  American City Business Journals]
▶ As Unemployment Scrapes 17-Year Lows, Headhunters Fill Niches   [May-21-18 02:14PM  Investor's Business Daily]
▶ AMN Healthcare to Present at Three Conferences in June   [May-14-18 07:00AM  PR Newswire]
▶ AMN Healthcare: 1Q Earnings Snapshot   [May-03-18 07:45PM  Associated Press]
▶ Fast-growing health staffing firm now dual-headquartered in North Texas, San Diego   [Apr-30-18 07:42AM  American City Business Journals]
▶ New Strong Buy Stocks for April 23rd   [Apr-23-18 11:18AM  Zacks]
▶ Coppell-based AMN Healthcare acquires multiple companies for over $225M   [Apr-16-18 02:30PM  American City Business Journals]
▶ /C O R R E C T I O N -- AMN Healthcare Services, Inc./   [Apr-11-18 10:44AM  PR Newswire]
▶ Fast-growing health care staffing firm in Tampa sells for $195M   [06:32AM  American City Business Journals]
▶ AMN Healthcare Completes Two Acquisitions   [Apr-09-18 04:15PM  PR Newswire]
▶ AMN Healthcare meets 4Q profit forecasts   [Feb-15-18 06:04PM  Associated Press]
▶ AMN Healthcare Announces New Revolving Credit Facility   [Feb-12-18 07:30AM  PR Newswire]
▶ The Motley Fool Makes Its ETF Debut   [Jan-30-18 03:29PM  ETF Trends]
▶ Stocks To Watch: AMN Healthcare Services Sees RS Rating Rise To 82   [Jan-05-18 03:00AM  Investor's Business Daily]
▶ 4 Reasons To Like AMN Healthcare   [Nov-17-17 10:01AM  Benzinga]
▶ AMN Healthcare beats Street 3Q forecasts   [05:37AM  Associated Press]
▶ AMN Healthcare Announces Third Quarter 2017 Results   [Nov-02-17 04:18PM  PR Newswire]
▶ AMN Healthcare Services Reaches 80-Plus Relative Strength Rating Benchmark   [Oct-06-17 03:00AM  Investor's Business Daily]
▶ Breakout Watch: Health Care Stock Just Shy Of New Buy Zone   [Sep-28-17 11:18AM  Investor's Business Daily]
▶ AMN Healthcare beats Street 2Q forecasts   [Aug-05-17 01:10AM  Associated Press]
▶ AMN Healthcare Announces Second Quarter 2017 Results   [Aug-03-17 04:19PM  PR Newswire]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.